1.380USDMkt Cap: 111.74M USDP/E: —Last update: 2026-05-21
Cibus, Inc. is an agricultural biotechnology company that develops and licenses gene-edited plant traits. The company's products enable farmers to achieve higher yields and reduce the use of chemicals, such as fungicides…
Industry Peers
Biotechnologyloading…
Indicators:|
Key Statistics
Company
Market Cap111.74M USD
Enterprise Value348.69M USD
Revenue (TTM)3.64M USD
Gross Profit3.64M USD
Net Income (TTM)-127.08M USD
Revenue/Share0.0800 USD
Last Price1.380 USD
Fiscal Year EndDec 2025
MR QuarterDec 2025
Employees118
CountryUS
SectorHealthcare
IndustryBiotechnology
ISIN—
Valuation
P/E (Trailing)—
P/E (Forward)-2.19
PEG—
EV/EBITDA-5.67
EV/Revenue95.82
P/S30.71
P/B3.43
EPS (TTM)-1.77
EPS (Forward)-0.63
52W Range
1.33059% of range1.415
52W High1.415 USD
52W Low1.330 USD
Profitability
Gross Margin100.00%
Oper. Margin-1273.32%
EBITDA Margin0.00%
Profit Margin-3492.31%
ROE-582.18%
ROA-41.66%
Growth
Revenue Growth-12.80%
Earnings Growth—
Cash Flow & Leverage
Operating CF-50.59M USD
CapEx (TTM)578.00K USD
FCF Margin-1423.21%
FCF Yield-46.35%
Net Debt258.04M USD
Net Debt/EBITDA-4.19
Balance Sheet
Debt/Equity1.51
Current Ratio0.72
Quick Ratio0.63
Book Value/Sh0.4020 USD
Cash/Share0.1430 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 USD
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Splits
Last Split1:5
Split DateJun 1, 2023
Analyst Consensus
Rating1.7 (Buy)
Target (Mean)14.67 USD
Target Range3.000 USD – 25.00 USD
# Analysts3
Ownership
Shares Out.76.33M
Float51.89M
Insiders24.72%
Institutions21.99%
Short Interest
Short Ratio6.9d
Short % Float7.78%
Short % Out.5.79%
Shares Short4.42M
Short (prev mo.)3.43M
Technical
SMA 501.849 (-25.4%)
SMA 2001.796 (-23.1%)
Beta1.66
S&P 52W Chg28.31%
Avg Vol (30d)146.20K
Avg Vol (10d)247.32K
Technical Indicators
RSI (14)—
MACD—
MACD Signal—
MACD Hist.—
BB Upper—
BB Middle—
BB Lower—
BB Width—
ATR (14)—
Vol Ratio (20d)—